105,766 Shares in Clover Health Investments, Corp. (NASDAQ:CLOV) Acquired by Barclays PLC

Barclays PLC bought a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 105,766 shares of the company’s stock, valued at approximately $298,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at $28,000. Sigma Planning Corp purchased a new stake in Clover Health Investments during the third quarter worth about $29,000. Parallax Volatility Advisers L.P. acquired a new stake in shares of Clover Health Investments during the third quarter worth about $38,000. Vanguard Personalized Indexing Management LLC boosted its stake in shares of Clover Health Investments by 54.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after purchasing an additional 12,104 shares during the period. Finally, Realta Investment Advisors acquired a new position in shares of Clover Health Investments in the third quarter valued at approximately $44,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Analysts Set New Price Targets

CLOV has been the topic of a number of research reports. Craig Hallum initiated coverage on shares of Clover Health Investments in a report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock. UBS Group assumed coverage on Clover Health Investments in a report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target on the stock.

Clover Health Investments Stock Up 0.2 %

NASDAQ CLOV opened at $4.08 on Tuesday. Clover Health Investments, Corp. has a 52 week low of $0.61 and a 52 week high of $4.71. The firm has a 50 day moving average of $3.36 and a two-hundred day moving average of $3.02. The stock has a market capitalization of $2.04 billion, a PE ratio of -20.40 and a beta of 1.95.

Clover Health Investments (NASDAQ:CLOV) last issued its earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The firm had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same quarter in the previous year, the firm posted ($0.09) earnings per share. On average, equities research analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.